Health Care & Life Sciences » Pharmaceuticals | Longrun Tea Group Co. Ltd.

Longrun Tea Group Co. Ltd. | Cash Flow

Fiscal year is April-March. All values HKD Thousands.
2012
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
60,891.00
6,145.00
15,138.00
207,441.00
4,799.00
32,167
33,887
Depreciation, Depletion & Amortization
13,801.00
17,391.00
19,902.00
20,956.00
4,665.00
1,414
1,045
Other Funds
6,728.00
9,177.00
5,590.00
2,027.00
5,033.00
19,103
6,012
Funds from Operations
61,148.00
14,683.00
36,902.00
12,585.00
1,753.00
11,650
26,830
Changes in Working Capital
66,688.00
30,120.00
40,816.00
24,225.00
1,616.00
1,572
34,510
Net Operating Cash Flow
127,836.00
15,437.00
3,914.00
36,810.00
3,369.00
10,078
61,340
Capital Expenditures
16,563.00
43,960.00
11,747.00
8,710.00
4,137.00
Sale of Fixed Assets & Businesses
175.00
6.00
83,633.00
796.00
84.00
Purchase/Sale of Investments
17.00
-
145.00
249.00
8,715.00
Net Investing Cash Flow
167,196.00
19,937.00
16,885.00
12,521.00
12,978.00
Issuance/Reduction of Debt, Net
4,291.00
513.00
11,868.00
264.00
318.00
Net Financing Cash Flow
2,437.00
8,855.00
17,458.00
1,763.00
5,351.00
Net Change in Cash
30,421.00
46,571.00
30,277.00
22,169.00
28,883.00
Free Cash Flow
111,273.00
28,523.00
7,833.00
45,520.00
7,506.00
Net Assets from Acquisitions
-
3,166.00
72.00
-
17,640.00
Other Sources
-
67,057.00
90.00
20,186.00
-
Change in Capital Stock
-
191.00
-
-
-
Exchange Rate Effect
6,502.00
2,342.00
152.00
357.00
7,185.00
Other Uses
150,791.00
-
88,934.00
-
-

About Longrun Tea Group Co.

View Profile
Address
Room 3007A-B
Hong Kong
Hong Kong
Employees -
Website http://www.longruntea.com
Updated 07/08/2019
Longrun Tea Group Co. Ltd. engaged in tea planting, processing, marketing, research, tea culture education and promotion. It operates through two segments: Manufacturing and distribution of pharmaceutical products and Distribution of tea and other food products. The manufacturing and distribution of pharmaceutical products segment engages in the manufacturing, sale and distribution of pharmaceutical products.